Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 15q14 Microdeletion Syndrome C4305230
Clinical comparison between 2p13 2 Microdeletion Syndrome and 15q14 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
15q14 Microdeletion Syndrome C4305230
A rare chromosomal condition where a small piece of chromosome 15 is missing. It can be associated with congenital heart defects, developmental delays, and distinctive facial features. Care focuses on addressing specific health and developmental needs.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
15q14 Microdeletion Syndrome C4305230
0-null
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
15q14 Microdeletion Syndrome C4305230
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
15q14 Microdeletion Syndrome C4305230
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
15q14 Microdeletion Syndrome C4305230
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
15q14 Microdeletion Syndrome C4305230
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
15q14 Microdeletion Syndrome C4305230
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 15q14-microdeletion-syndrome-C4305230 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 15q14 Microdeletion Syndrome C4305230 | Discriminating power |
|---|---|---|---|
| Chromosomal location | Small missing segment involving 2p13.2; features vary by affected genes. | Small missing segment involving 15q14. | High |
| Reported clinical pattern | No single symptom pattern is established in the supplied description. | May include congenital heart defects, developmental delay, and distinctive facial features. | Moderate |
| Source severity label | Labeled severe, although individual effects are not specified here. | Labeled moderate, with variable health and developmental needs. | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
A validated genetic test identifies a deletion at 2p13.2.
The chromosomal region is the principal distinction supplied.
High
The phenotype is variable and lacks features specifically tied here to 15q14.
Features depend on the genes affected and require correlation.
Moderate
Planning support for potentially severe congenital effects.
The severe label does not itself confirm the diagnosis.
Low
Choose 15q14 Microdeletion Syndrome C4305230 when
A validated genetic test identifies a deletion at 15q14.
Location distinguishes it from a 2p13.2 deletion.
High
Heart defects, developmental delay, or facial differences prompt targeted review.
These are reported associations, not proof alone.
Moderate
Care is organized around moderate but ongoing developmental needs.
The severity label should be individualized by clinicians.
Low
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 15q14 Microdeletion Syndrome C4305230 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or equivalent genetic test | Deletion involving 2p13.2. | Deletion involving 15q14. | The region supports distinction; laboratory and clinical correlation are required. |
| Echocardiography | No specific cardiac expectation is established here. | May detect a congenital heart defect when suspected. | An abnormal result is a finding, not a syndrome diagnosis. |
| Developmental assessment | Delays are not specifically established by the supplied data. | Developmental delay is a reported association. | Assessment guides support but does not replace genetic confirmation. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; the source labels severity as severe.
- Factors
- Affected genes, anomalies, and available support.
15q14 Microdeletion Syndrome C4305230
- Outcome
- Outcome is variable; the source labels severity as moderate.
- Factors
- Heart findings, developmental needs, and supportive care.
Time frame: Both are chronic, generally lifelong conditions; exact milestones are not established.
Genetic result, organ involvement, development, and follow-up influence course.
Complications comparison
| Complication | Presentation |
|---|---|
| Congenital heart defect | Not established in the supplied description. A reported possible association. Cardiac findings need separate clinical evaluation. |
| Developmental needs | May vary with the genes involved. Developmental delay may occur. Early assessment can guide individualized therapies. |
| Unspecified organ complications | Exact complications are not established here. Beyond listed associations, complications are not fully specified. Specialist review should determine surveillance. |
Patient education highlights
- HighConfirmation
The diagnosis depends on the missing chromosomal region plus clinician interpretation.
- HighTransmission
Neither condition is communicable from person to person.
- MediumCare
Management addresses each person’s specific medical and developmental needs.